In a move aimed at strengthening public trust while preserving strong protection against serious childhood disease, the Centers for Disease Control and Prevention (CDC) has formally accepted recommendations to update the U.S. childhood immunization schedule. The decision follows a Presidential Memorandum directing federal health leaders to review international best practices and align U.S. policy with the strongest available scientific evidence.
Signed by Deputy Secretary of Health and Human Services Jim O’Neill in his role as Acting Director of the Centers for Disease Control and Prevention, the decision memorandum adopts the findings of a comprehensive scientific assessment comparing U.S. immunization practices with those of peer, developed nations. The review was conducted at the direction of Donald Trump, who instructed federal agencies to update the schedule if superior approaches existed abroad—while preserving access to all vaccines currently available to American families.
A Thoughtful, Evidence-Driven Review
The assessment examined childhood vaccination schedules in 20 peer, developed countries, evaluating clinical and epidemiological evidence, vaccination uptake, public trust, and the role of education versus mandates. It found that while the United States has historically recommended protection against more diseases—and more total doses—than any peer nation, it does not achieve higher vaccination rates or better outcomes as a result. In fact, many countries with more focused schedules maintain strong child health outcomes and high vaccination rates through clarity, education, and public confidence.
One illustrative comparison highlighted Denmark, which immunizes children against fewer diseases while sustaining high trust and adherence. The assessment concluded that a more streamlined approach, aligned with international consensus, could improve understanding and confidence without sacrificing protection.
After reviewing the findings and a decision memo presented by Jay Bhattacharya, Marty Makary, and Mehmet Oz, Acting Director O’Neill formally accepted the recommendations and directed CDC to proceed with implementation.
Preserving Protection While Rebuilding Trust
Secretary of Health and Human Services Robert F. Kennedy Jr. emphasized that the updated schedule reflects both scientific rigor and respect for families. By aligning U.S. recommendations with global best practices, HHS aims to protect children while strengthening transparency and informed consent—key ingredients for rebuilding confidence in public health institutions.
The assessment also addressed a documented decline in public trust between 2020 and 2024, a period marked by falling childhood vaccination rates and increased vulnerability to vaccine-preventable diseases. Federal health leaders were clear: public health works best when people trust the process and understand the rationale behind recommendations.
How the Updated Schedule Is Organized
Under the accepted recommendations, CDC will continue to organize childhood immunizations into three clear categories. Importantly, all vaccines currently recommended by CDC will remain covered by insurance without cost-sharing, ensuring that no family loses access as a result of these changes.
- Immunizations recommended for all children, including vaccines for measles, mumps, rubella, polio, pertussis, tetanus, diphtheria, Haemophilus influenzae type B (Hib), pneumococcal disease, human papillomavirus (HPV), and varicella (chickenpox).
- Immunizations recommended for certain high-risk groups or based on shared clinical decision-making, allowing physicians and parents to tailor choices to individual health needs and risk profiles.
This framework preserves robust baseline protection while empowering families and clinicians to make informed, individualized decisions—an approach widely used by peer nations with strong outcomes.
A Commitment to Gold-Standard Science
A central theme of the assessment is the importance of continuous scientific evaluation. The recommendations call for expanded investment in gold-standard research, including placebo-controlled randomized trials and long-term observational studies, to better characterize vaccine benefits, risks, and outcomes over time.
Dr. Bhattacharya underscored that science is not static. By committing the National Institutes of Health, CDC, and the Food and Drug Administration to ongoing reassessment as new data emerge, the policy ensures that recommendations will evolve with the evidence—strengthening credibility and confidence.
Benefits of the Updated Approach
The accepted recommendations reflect a balanced, forward-looking strategy designed to serve children, families, and the broader public health system.
- Focused protection against the most serious infectious diseases, with continued universal coverage and insurance support.
- Greater clarity and transparency, improving understanding, adherence, and trust among parents and clinicians.
By emphasizing education and shared decision-making alongside strong baseline recommendations, the updated schedule mirrors successful international models while remaining tailored to the U.S. health care landscape.
Moving Toward Implementation
HHS and CDC will now work closely with state health agencies, physician groups, and other partners to implement the updated schedule. Outreach and education efforts will help parents and clinicians understand what is changing—and what is not—ensuring a smooth transition grounded in clarity and confidence.
Dr. Makary noted that restoring trust requires openness and respect. This update, he said, recommits federal health institutions to transparency, rigorous science, and partnership with families. Dr. Oz added that maintaining insurance coverage for all recommended vaccines ensures continuity of care while giving families greater flexibility within a trusted framework.
A Reset with Long-Term Vision
Taken together, the updated childhood immunization schedule represents a significant reset in U.S. vaccine policy—one that aligns with international consensus, strengthens scientific foundations, and places trust at the center of public health. By protecting access, prioritizing the most serious diseases, and committing to ongoing evaluation, the CDC’s action signals a renewed commitment to both child health and public confidence.
As implementation moves forward, federal health leaders have made clear that this is not a retreat from vaccination, but an evolution toward a more focused, transparent, and trusted system—one designed to protect children today and earn the confidence of families for generations to come.